Volume Alert - AGN 212.46 Allergan Inc $AGN Hit a
Post# of 58
Posted On: 11/18/2014 11:54:06 AM
Volume Alert - AGN 212.46 Allergan Inc $AGN Hit a high today of 213.60 Closing the day 10:30 at 212.46 +3.26 +1.56% With a day low of 207.18 and a total volume of 2,902,723.
AGN Recent Posts: http://investorshangout.com/Allergan-AGN-50031/
AGN Allergan Inc Recent Headline News
Stock Market Today: S&P 500 Flexes Muscles After Global Markets Pop
at The Street - 2 mins ago
The S&P 500 shows some muscle on Tuesday, rocketing to a new record high as global markets rally.
URBN: 28.08 (-2.75), AGN: 212.00 (+2.80), HD: 96.05 (-1.98), ACT: 261.86 (+13.92), TERP: 33.66 (+7.82), TJX: 60.06 (-1.48), MDT: 71.87 (+2.68), GILD: 101.85 (+1.41), SUNE: 20.56 (+3.95), HIMX: 6.54 (-0.36), AAPL: 114.55 (+0.56), NOK: 7.98 (+0.31)
Jim Cramer: Which Stocks Stand Out as Winners? Here's My List
at The Street - 6 mins ago
There's a powerful collection of 'what's working.'
HON: 96.83 (+0.30), JAH: 66.82 (+0.13), CAH: 80.83 (+0.47), WMT: 83.73 (+0.16), PDCO: 46.64 (+0.38), EAT: 54.07 (+0.11), UPS: 106.53 (+0.06), JACK: 70.90 (+0.61), DLTR: 61.75 (+0.28), TGT: 66.73 (-0.40), COST: 139.00 (+0.53), AAL: 44.60 (+0.91), DG: 65.39 (+0.09), LOW: 58.18 (-0.71), MSFT: 49.05 (-0.41), HSIC: 131.98 (+1.04), BCR: 166.78 (+1.97), MCK: 205.18 (+0.80), IP: 54.92 (+0.08), EW: 127.31 (+1.08), FDO: 78.86 (unch), AZO: 567.52 (-0.54), MCD: 96.29 (+0.32), SHW: 240.50 (+1.19), XRAY: 53.10 (+0.49), AN: 57.47 (+0.13), F: 15.38 (-0.16), ACT: 261.86 (+13.92), BDX: 130.52 (+0.98), VRX: 141.47 (+4.74), MDT: 71.87 (+2.68), SNA: 136.04 (+1.15), GMCR: 157.75 (+3.25), AGN: 212.00 (+2.80), KMX: 55.15 (+0.49), YHOO: 51.83 (-0.54), WHR: 177.36 (+1.81), CMG: 659.71 (+1.39), AAPL: 114.55 (+0.56), AMZN: 327.03 (+3.98), HD: 96.05 (-1.98), ORLY: 177.75 (+0.45), FRGI: 56.52 (+0.86), ABC: 89.20 (+0.19), TJX: 60.06 (-1.48), GM: 32.16 (-0.15), JWN: 72.94 (-0.33), ROST: 80.59 (-0.75)
AGN INVESTOR ALERT: Levi & Korsinsky, LLP Announces Investigation of the Board of Directors of Allergan Inc. in Connection With the Fairness of the Sale of the Company to Actavis plc -- AGN
PR Newswire - 35 mins ago
Levi & Korsinsky is investigating the Board of Directors of Allergan Inc. ("Allergan" or "the Company"
(NYSE: AGN) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to Actavis plc.
AGN: 212.00 (+2.80)
Stock Market News for November 18, 2014 - Market News
Zacks Equity Research - Zacks Investment Research - 1 hr 43 mins ago
Markets ended its choppy run yesterday on a mixed note after Japan unexpectedly slipped into a recession
AGN: 212.00 (+2.80), ACT: 261.84 (+13.90), EOG: 97.23 (+0.88), HAL: 49.35 (+0.12), HP: 77.46 (-0.79), MRO: 31.89 (+0.07), BHI: 65.38 (+0.15)
Zacks Investment Ideas feature highlights: Allergan, Actavis, Sketchers and Zeltiq Aesthetics
PR Newswire - 2 hrs 23 mins ago
Today, Zacks Investment Ideas feature highlights Features: Allergan (NYSE:AGN-Free Report), Actavis (NYSE:ACT-Free Report), Sketchers (NYSE:SKX-Free Report) and Zeltiq Aesthetics (Nasdaq:ZLTQ-Free Report).
AGN: 212.00 (+2.80)
Winners And Losers In The Allergan Valeant Actavis Melee; Also, Will Bill Ackman Lose His Profit?
Uncommon Profit Investor - at Seeking Alpha - Tue Nov 18, 7:32AM CST
AGN: 212.00 (+2.80), VRX: 141.47 (+4.74), ACT: 261.84 (+13.90)
Downgrade Alert for Allergan (AGN)
Comtex SmarTrend(R) - Tue Nov 18, 6:55AM CST
Allergan (AMEX:AGN) was downgraded from Buy to Neutral at Guggenheim today. The stock closed yesterday at $209.20 on volume of 19.1 million shares, above average daily volume of 2.7 million. In the past 52 weeks, Allergan share prices have been bracketed by a low of $94.98 and a high of $213.91 and closed yesterday at $209.20, 120% above that low price. Over the past week, the 200-day moving average (MA) has gone up 0.8% while the 50-day MA has advanced 1.2%.
AGN: 212.00 (+2.80)
Jim Cramer's 'Mad Money' Recap: When Bad News Is Really Good News for Us
at The Street - Mon Nov 17, 7:09PM CST
Cramer says this morning's losses and afternoon's gains prove that not all markets need to trade in tandem.
CST: 42.97 (+1.06), BIIB: 304.65 (+2.23), GE: 26.91 (+0.30), NKE: 96.10 (+0.04), HAL: 49.33 (+0.10), TSN: 42.58 (-0.45), GSAT: 2.53 (-0.27), LULU: 44.96 (+0.54), AGN: 212.00 (+2.80), MACK: 8.84 (+0.22), WHR: 177.36 (+1.81), UA: 68.69 (-0.20), DSX: 7.84 (+0.02), ALNY: 90.38 (+1.40), MPC: 93.69 (+1.18), JCP: 7.35 (+0.09), SHW: 240.50 (+1.19), MBLY: 47.42 (+0.44), REGN: 409.72 (+10.07), BHI: 65.40 (+0.17)
Here Are Some Big Caps Poised To Make Gains
at Investor's Business Daily - Mon Nov 17, 5:45PM CST
Several Big Cap 20 stocks have recently broken out of bases, but are still within buy range, or are building new bases and could be good additions to a watch list. Alexion Pharmaceuticals (ALXN) has pulled back and is within the 5% buy zone. The...
AGN: 212.00 (+2.80), ACT: 261.83 (+13.89), VRX: 141.47 (+4.74), V: 249.63 (-0.17), ALXN: 190.80 (+4.02), CTSH: 52.85 (-0.21), MA: 83.64 (+0.44), ADS: 281.21 (+0.33)
Merck Updates on Anti-PD-1 Drug Keytruda Phase II Study - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Nov 17, 5:30PM CST
Merck's (MRK) anti-PD-1 therapy, Keytruda, met the primary endpoint of progression free survival as compared to chemotherapy in a phase II study (KEYNOTE-002).
AGN: 212.00 (+2.80), MRK: 60.05 (+0.59), ABBV: 65.82 (+0.78), BMY: 58.70 (+0.27)
Bristol-Myers Squibb Reports Positive Opdivo Phase III Data - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Nov 17, 5:20PM CST
Bristol-Myers Squibb Company announced encouraging data from the phase III CheckMate - 066 study on immuno-oncology drug Opdivo.
AGN: 212.00 (+2.80), ACT: 261.83 (+13.89), AMAG: 36.25 (+1.49), BMY: 58.70 (+0.27)
NYSE stocks posting largest volume increases
AP - Mon Nov 17, 5:02PM CST
NEW YORK (AP) — A look at the 10 biggest volume gainers on New York Stock Exchange at the close of trading:
AGN: 212.00 (+2.80), HAL: 49.34 (+0.11), BLT: 16.64 (+0.47), DKL: 40.28 (+0.28), BHI: 65.40 (+0.17)
Watch for Allergan to Potentially Pullback After Gaining 5.21% Yesterday
Comtex SmarTrend(R) - Mon Nov 17, 4:28PM CST
Allergan (AMEX:AGN) traded in a range yesterday that spanned from a low of $207.44 to a high of $213.91. Yesterday, the shares gained 5.2%, which took the trading range above the 3-day high of $200.60 on volume of 18.9 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
AGN: 212.00 (+2.80)
Actavis to spend $66 billion on Allergan
By TOM MURPHY - AP - Mon Nov 17, 4:01PM CST
Actavis, which is buying Botox-maker Allergan for $66 billion in one of the biggest acquisitions announced so far this year, plans to stay committed to developing new products.
1 Comment
DRTX: 24.16 (+0.41), AGN: 212.00 (+2.80), ACT: 261.83 (+13.89), VRX: 141.47 (+4.74), MRK: 60.05 (+0.59), VRX.TO: 160.05 (+5.65)
Halliburton and Allergan are big market movers
AP - Mon Nov 17, 3:33PM CST
NEW YORK (AP) — Stocks that moved substantially or traded heavily Monday on the New York Stock Exchange and the Nasdaq Stock Market:
EXH: 36.99 (+0.18), AGN: 212.00 (+2.80), HAS: 56.00 (-0.37), HAL: 49.35 (+0.12), DNR: 9.88 (-0.13), MITL: 10.21 (+0.01), FOLD: 6.27 (-0.43), BHI: 65.40 (+0.17)
Stocks End Mixed As Allergan Jumps On Actavis Deal
at Investor's Business Daily - Mon Nov 17, 3:16PM CST
Major averages pared losses from a late-morning slump to end mixed amid big merger deals and weak economic data. The S&P 500 and Dow Jones industrial average closed fractionally higher, while the Nasdaq fell 0.4%. Volume ran lower across the board in...
AGN: 212.00 (+2.80), VRX: 141.47 (+4.74), ACT: 261.83 (+13.89), SAFM: 86.21 (+1.28), PPC: 31.49 (+0.55), MIK: 22.04 (+0.39), TSN: 42.58 (-0.45)
Stock Market Today: Japan Recession Keeps Markets From Celebrating Deals Deluge
at The Street - Mon Nov 17, 3:15PM CST
Wheelings and dealings from top pharmaceutical giants and energy companies momentarily distracts Wall Street from worrying news Japan has fallen into recession in its third quarter.
AMZN: 327.03 (+3.98), HAS: 56.00 (-0.37), ACT: 261.83 (+13.89), VRX: 141.47 (+4.74), JIVE: 6.43 (+0.06), FB: 74.09 (-0.15), HAL: 49.33 (+0.10), DWA: 22.21 (-0.10), AGN: 212.00 (+2.80), LNKD: 223.92 (+0.64), BHI: 65.40 (+0.17), CRM: 62.83 (+0.32)
Stocks Mixed In Afternoon; Allergan Jumps To New High
at Investor's Business Daily - Mon Nov 17, 2:13PM CST
Stocks remained mixed late Monday afternoon as investors weighed a spate of merger activity against news that Japan fell into a recession. The Dow Jones industrial average and the S&P 500 were each up 0.1%, while the Nasdaq was down 0.3%. Volume was...
AGN: 212.00 (+2.80), VRX: 141.47 (+4.74), ACT: 261.83 (+13.89), LNKD: 223.92 (+0.64), FB: 74.09 (-0.15), HAL: 49.33 (+0.10), BHI: 65.40 (+0.17), Z: 116.30 (-1.56)
Most active New York Stock Exchange-traded stocks
AP - Mon Nov 17, 1:22PM CST
NEW YORK (AP) — A look at New York Stock Exchange 10 most-active stocks at 1 p.m.:
AGN: 212.00 (+2.80), GE: 26.91 (+0.30), F: 15.39 (-0.15), PFE: 30.64 (+0.32), HAL: 49.33 (+0.10), BAC: 17.17 (+0.08), DNR: 9.88 (-0.13), TWTR: 40.29 (-0.18), BHI: 65.40 (+0.17)
AGN Recent Posts: http://investorshangout.com/Allergan-AGN-50031/
AGN Allergan Inc Recent Headline News
Stock Market Today: S&P 500 Flexes Muscles After Global Markets Pop
at The Street - 2 mins ago
The S&P 500 shows some muscle on Tuesday, rocketing to a new record high as global markets rally.
URBN: 28.08 (-2.75), AGN: 212.00 (+2.80), HD: 96.05 (-1.98), ACT: 261.86 (+13.92), TERP: 33.66 (+7.82), TJX: 60.06 (-1.48), MDT: 71.87 (+2.68), GILD: 101.85 (+1.41), SUNE: 20.56 (+3.95), HIMX: 6.54 (-0.36), AAPL: 114.55 (+0.56), NOK: 7.98 (+0.31)
Jim Cramer: Which Stocks Stand Out as Winners? Here's My List
at The Street - 6 mins ago
There's a powerful collection of 'what's working.'
HON: 96.83 (+0.30), JAH: 66.82 (+0.13), CAH: 80.83 (+0.47), WMT: 83.73 (+0.16), PDCO: 46.64 (+0.38), EAT: 54.07 (+0.11), UPS: 106.53 (+0.06), JACK: 70.90 (+0.61), DLTR: 61.75 (+0.28), TGT: 66.73 (-0.40), COST: 139.00 (+0.53), AAL: 44.60 (+0.91), DG: 65.39 (+0.09), LOW: 58.18 (-0.71), MSFT: 49.05 (-0.41), HSIC: 131.98 (+1.04), BCR: 166.78 (+1.97), MCK: 205.18 (+0.80), IP: 54.92 (+0.08), EW: 127.31 (+1.08), FDO: 78.86 (unch), AZO: 567.52 (-0.54), MCD: 96.29 (+0.32), SHW: 240.50 (+1.19), XRAY: 53.10 (+0.49), AN: 57.47 (+0.13), F: 15.38 (-0.16), ACT: 261.86 (+13.92), BDX: 130.52 (+0.98), VRX: 141.47 (+4.74), MDT: 71.87 (+2.68), SNA: 136.04 (+1.15), GMCR: 157.75 (+3.25), AGN: 212.00 (+2.80), KMX: 55.15 (+0.49), YHOO: 51.83 (-0.54), WHR: 177.36 (+1.81), CMG: 659.71 (+1.39), AAPL: 114.55 (+0.56), AMZN: 327.03 (+3.98), HD: 96.05 (-1.98), ORLY: 177.75 (+0.45), FRGI: 56.52 (+0.86), ABC: 89.20 (+0.19), TJX: 60.06 (-1.48), GM: 32.16 (-0.15), JWN: 72.94 (-0.33), ROST: 80.59 (-0.75)
AGN INVESTOR ALERT: Levi & Korsinsky, LLP Announces Investigation of the Board of Directors of Allergan Inc. in Connection With the Fairness of the Sale of the Company to Actavis plc -- AGN
PR Newswire - 35 mins ago
Levi & Korsinsky is investigating the Board of Directors of Allergan Inc. ("Allergan" or "the Company"
(NYSE: AGN) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to Actavis plc. AGN: 212.00 (+2.80)
Stock Market News for November 18, 2014 - Market News
Zacks Equity Research - Zacks Investment Research - 1 hr 43 mins ago
Markets ended its choppy run yesterday on a mixed note after Japan unexpectedly slipped into a recession
AGN: 212.00 (+2.80), ACT: 261.84 (+13.90), EOG: 97.23 (+0.88), HAL: 49.35 (+0.12), HP: 77.46 (-0.79), MRO: 31.89 (+0.07), BHI: 65.38 (+0.15)
Zacks Investment Ideas feature highlights: Allergan, Actavis, Sketchers and Zeltiq Aesthetics
PR Newswire - 2 hrs 23 mins ago
Today, Zacks Investment Ideas feature highlights Features: Allergan (NYSE:AGN-Free Report), Actavis (NYSE:ACT-Free Report), Sketchers (NYSE:SKX-Free Report) and Zeltiq Aesthetics (Nasdaq:ZLTQ-Free Report).
AGN: 212.00 (+2.80)
Winners And Losers In The Allergan Valeant Actavis Melee; Also, Will Bill Ackman Lose His Profit?
Uncommon Profit Investor - at Seeking Alpha - Tue Nov 18, 7:32AM CST
AGN: 212.00 (+2.80), VRX: 141.47 (+4.74), ACT: 261.84 (+13.90)
Downgrade Alert for Allergan (AGN)
Comtex SmarTrend(R) - Tue Nov 18, 6:55AM CST
Allergan (AMEX:AGN) was downgraded from Buy to Neutral at Guggenheim today. The stock closed yesterday at $209.20 on volume of 19.1 million shares, above average daily volume of 2.7 million. In the past 52 weeks, Allergan share prices have been bracketed by a low of $94.98 and a high of $213.91 and closed yesterday at $209.20, 120% above that low price. Over the past week, the 200-day moving average (MA) has gone up 0.8% while the 50-day MA has advanced 1.2%.
AGN: 212.00 (+2.80)
Jim Cramer's 'Mad Money' Recap: When Bad News Is Really Good News for Us
at The Street - Mon Nov 17, 7:09PM CST
Cramer says this morning's losses and afternoon's gains prove that not all markets need to trade in tandem.
CST: 42.97 (+1.06), BIIB: 304.65 (+2.23), GE: 26.91 (+0.30), NKE: 96.10 (+0.04), HAL: 49.33 (+0.10), TSN: 42.58 (-0.45), GSAT: 2.53 (-0.27), LULU: 44.96 (+0.54), AGN: 212.00 (+2.80), MACK: 8.84 (+0.22), WHR: 177.36 (+1.81), UA: 68.69 (-0.20), DSX: 7.84 (+0.02), ALNY: 90.38 (+1.40), MPC: 93.69 (+1.18), JCP: 7.35 (+0.09), SHW: 240.50 (+1.19), MBLY: 47.42 (+0.44), REGN: 409.72 (+10.07), BHI: 65.40 (+0.17)
Here Are Some Big Caps Poised To Make Gains
at Investor's Business Daily - Mon Nov 17, 5:45PM CST
Several Big Cap 20 stocks have recently broken out of bases, but are still within buy range, or are building new bases and could be good additions to a watch list. Alexion Pharmaceuticals (ALXN) has pulled back and is within the 5% buy zone. The...
AGN: 212.00 (+2.80), ACT: 261.83 (+13.89), VRX: 141.47 (+4.74), V: 249.63 (-0.17), ALXN: 190.80 (+4.02), CTSH: 52.85 (-0.21), MA: 83.64 (+0.44), ADS: 281.21 (+0.33)
Merck Updates on Anti-PD-1 Drug Keytruda Phase II Study - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Nov 17, 5:30PM CST
Merck's (MRK) anti-PD-1 therapy, Keytruda, met the primary endpoint of progression free survival as compared to chemotherapy in a phase II study (KEYNOTE-002).
AGN: 212.00 (+2.80), MRK: 60.05 (+0.59), ABBV: 65.82 (+0.78), BMY: 58.70 (+0.27)
Bristol-Myers Squibb Reports Positive Opdivo Phase III Data - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Nov 17, 5:20PM CST
Bristol-Myers Squibb Company announced encouraging data from the phase III CheckMate - 066 study on immuno-oncology drug Opdivo.
AGN: 212.00 (+2.80), ACT: 261.83 (+13.89), AMAG: 36.25 (+1.49), BMY: 58.70 (+0.27)
NYSE stocks posting largest volume increases
AP - Mon Nov 17, 5:02PM CST
NEW YORK (AP) — A look at the 10 biggest volume gainers on New York Stock Exchange at the close of trading:
AGN: 212.00 (+2.80), HAL: 49.34 (+0.11), BLT: 16.64 (+0.47), DKL: 40.28 (+0.28), BHI: 65.40 (+0.17)
Watch for Allergan to Potentially Pullback After Gaining 5.21% Yesterday
Comtex SmarTrend(R) - Mon Nov 17, 4:28PM CST
Allergan (AMEX:AGN) traded in a range yesterday that spanned from a low of $207.44 to a high of $213.91. Yesterday, the shares gained 5.2%, which took the trading range above the 3-day high of $200.60 on volume of 18.9 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
AGN: 212.00 (+2.80)
Actavis to spend $66 billion on Allergan
By TOM MURPHY - AP - Mon Nov 17, 4:01PM CST
Actavis, which is buying Botox-maker Allergan for $66 billion in one of the biggest acquisitions announced so far this year, plans to stay committed to developing new products.
1 Comment
DRTX: 24.16 (+0.41), AGN: 212.00 (+2.80), ACT: 261.83 (+13.89), VRX: 141.47 (+4.74), MRK: 60.05 (+0.59), VRX.TO: 160.05 (+5.65)
Halliburton and Allergan are big market movers
AP - Mon Nov 17, 3:33PM CST
NEW YORK (AP) — Stocks that moved substantially or traded heavily Monday on the New York Stock Exchange and the Nasdaq Stock Market:
EXH: 36.99 (+0.18), AGN: 212.00 (+2.80), HAS: 56.00 (-0.37), HAL: 49.35 (+0.12), DNR: 9.88 (-0.13), MITL: 10.21 (+0.01), FOLD: 6.27 (-0.43), BHI: 65.40 (+0.17)
Stocks End Mixed As Allergan Jumps On Actavis Deal
at Investor's Business Daily - Mon Nov 17, 3:16PM CST
Major averages pared losses from a late-morning slump to end mixed amid big merger deals and weak economic data. The S&P 500 and Dow Jones industrial average closed fractionally higher, while the Nasdaq fell 0.4%. Volume ran lower across the board in...
AGN: 212.00 (+2.80), VRX: 141.47 (+4.74), ACT: 261.83 (+13.89), SAFM: 86.21 (+1.28), PPC: 31.49 (+0.55), MIK: 22.04 (+0.39), TSN: 42.58 (-0.45)
Stock Market Today: Japan Recession Keeps Markets From Celebrating Deals Deluge
at The Street - Mon Nov 17, 3:15PM CST
Wheelings and dealings from top pharmaceutical giants and energy companies momentarily distracts Wall Street from worrying news Japan has fallen into recession in its third quarter.
AMZN: 327.03 (+3.98), HAS: 56.00 (-0.37), ACT: 261.83 (+13.89), VRX: 141.47 (+4.74), JIVE: 6.43 (+0.06), FB: 74.09 (-0.15), HAL: 49.33 (+0.10), DWA: 22.21 (-0.10), AGN: 212.00 (+2.80), LNKD: 223.92 (+0.64), BHI: 65.40 (+0.17), CRM: 62.83 (+0.32)
Stocks Mixed In Afternoon; Allergan Jumps To New High
at Investor's Business Daily - Mon Nov 17, 2:13PM CST
Stocks remained mixed late Monday afternoon as investors weighed a spate of merger activity against news that Japan fell into a recession. The Dow Jones industrial average and the S&P 500 were each up 0.1%, while the Nasdaq was down 0.3%. Volume was...
AGN: 212.00 (+2.80), VRX: 141.47 (+4.74), ACT: 261.83 (+13.89), LNKD: 223.92 (+0.64), FB: 74.09 (-0.15), HAL: 49.33 (+0.10), BHI: 65.40 (+0.17), Z: 116.30 (-1.56)
Most active New York Stock Exchange-traded stocks
AP - Mon Nov 17, 1:22PM CST
NEW YORK (AP) — A look at New York Stock Exchange 10 most-active stocks at 1 p.m.:
AGN: 212.00 (+2.80), GE: 26.91 (+0.30), F: 15.39 (-0.15), PFE: 30.64 (+0.32), HAL: 49.33 (+0.10), BAC: 17.17 (+0.08), DNR: 9.88 (-0.13), TWTR: 40.29 (-0.18), BHI: 65.40 (+0.17)
(0)
(0)